Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers

The use of so-called ‘smart drugs’ such as modafinil to improve cognitive performance has recently attracted considerable attention. However, their side effects have limited user enthusiasm. Open-label placebo (OLP) treatment, i.e., inert treatments that are openly disclosed to individuals as having...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartmann, Helena, Forkmann, Katarina, Schmidt, Katharina, Kleine-Borgmann, Julian, Albers, Johanna, Wiech, Katja, Bingel, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636058/
https://www.ncbi.nlm.nih.gov/pubmed/37945662
http://dx.doi.org/10.1038/s41598-023-45979-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636058/
https://www.ncbi.nlm.nih.gov/pubmed/37945662
http://dx.doi.org/10.1038/s41598-023-45979-3

Ejemplares similares